Contract Injectable Packaging Trends in the Bio/Pharma Industry
Summary
This expert trend report is a comprehensive look at the injectable packaging landscape in 2022, including analysis of packaging outsourcing relationships for drugs, packaging companies and facilities. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
Scope
This 94-page report gives an important expert quantitative analysis of the commercial contract injectable drug packaging industry. Findings are based on the industry’s most comprehensive databases of the CMO industry (GlobalData's Contract Service Providers and Drugs by Manufacturer Database), which are continuously updated and refined. The 7 tables and 37 figures throughout the report illustrate major points and trends. This report is required reading for -
– CMO executives and strategic decision-makers: improves understanding of the injectable packaging industry and is a critical input for strategic planning efforts.– Sourcing and procurement executives in bio/pharmaceutical companies: improving understanding of crucial components of the supply base that will provide insights for supplier selection and management.– Private equity investors: they can deeper understanding of the injectable packaging market and important insight for identifying potential investment targets.
Reasons to Buy
This report will enable the user to answer the following questions -
- Who are the top players for injectable drug packaging?
- What are the approval trends for injectable pharmaceuticals?
- What types of packaging are most utilized for injectable drug packaging?
- Which contract packagers secured the most injectable packaging contracts?
- What is the outsourcing propensity when it comes to injectable packaging?
- What are the characteristics of companies operating in the contract packaging space?
- What is the geographic distribution of injectable packaging facilities?
- What types of injectable packaging are offered by sites?
- What M&A deals related to injectable packaging took place between 2019-22?
- About GlobalData
- Executive Summary
- Players
- Table Figure 1: Leading contract packaging players, 2021
- Technology Briefing
- Injectables and their packaging
- Outsourcing the packaging of injectable drugs
- Trends
- Table Figure 2: Injectable packaging trends, 2021
- Table Injectable packaging trends, 2021
- Industry Analysis
- Introduction
- Trends in injectable approvals
- Table Figure 3: FDA NDA and BLA injectable approvals, 2012-21
- Table Figure 4: EMA injectable non-generic approvals, 2012-21
- Cell and gene therapies
- Emerging sponsors and their injectable products
- Special designation products
- Table Figure 5: Orphan injectable approvals, 2012-21
- Table Figure 6: Fast track injectable approvals, 2012-21
- Table Figure 7: Breakthrough injectable approvals, 2012-21
- ANDA approvals
- Table Figure 8: ANDA injectable approvals, 2012-21
- Injectable approvals by sponsor type
- Table Figure 9: FDA NDA injectables approvals by sponsor type, 2012-21
- Table Figure 10: EMA non-generic injectables approvals by sponsor type, 2012-21
- Primary packaging of approved injectables
- Table Figure 11: FDA and EMA injectables approvals packaging, 2012-21
- Table Figure 12: Top contract packagers for injectables approvals packaging (by contract business model), 2012-21
- Table Figure 13: Top contract packagers for injectables approvals packaging (by focus), 2012-21
- Table Figure 14: Top sponsors for injectables approvals packaging contracts, 2012-21
- Trends in innovator injectable approvals - outsourcing
- Table Figure 15: FDA NDA injectables approvals outsourcing propensity, 2012-21
- Table Figure 16: EMA non-generic injectable packaging approvals outsourcing propensity, 2012-21
- Table Figure 17: FDA NDA injectable packaging approvals requiring special handling and their outsourcing, 2012-21
- Table Figure 18: FDA NDA injectables packaging outsourcing by top five molecule type, 2012-21
- Contract packagers of injectables by company
- Table Figure 19: Contract packagers by company type
- Table Figure 20: Contract packagers by contract business model
- Table Figure 21: Contract packagers by company type and contract business model
- New and promising contract packagers
- Contract packagers of injectables by facility
- Table Figure 22: Global map of contract packagers facilities by contract business model
- Table Figure 23: Global map of contract prefilled syringe packager facilities by contract business model
- Table Figure 24: Global map of contract blow fill seal packager facilities by contract business model
- Table Figure 25: Top contract injectable packagers by integrated packaging sites
- Table Figure 26: Top injectable contract packagers by standalone packaging sites
- Table Figure 27: Percentage of injectable packaging sites offering specific package types
- Injectable contract packaging universe
- Table Figure 28: Injectable contract packager sites by FDA and/or EMA regulatory approval
- Table M&A deals for dedicated contract injectable packagers, 2019-22
- Table New injectable packaging plants opened in 2021
- Table Capital raising deals for dedicated contract injectable packagers, 2019-22
- FDA and EMA packaging regulation track and trace regulatory for secondary packaging and drug/device FDA regulation updates
- FDA: track and trace/DSCSA
- EMA: Falsified Medicines Directive
- Injectable packaging contract manufacturing agreements for pipeline drugs
- Table Figure 29: Injectable contract manufacturing agreements by therapy area, 2018-22
- Table Figure 30: Top nine injectable contract manufacturing agreements by deal country
- Table Figure 31: Injectable contract manufacturing agreements by sponsor for pipeline drugs (highest stage), 2012-21
- Table Figure 32: Injectable contract manufacturing agreements by CMO, 2012-21
- Trends in the injectable pipeline
- Table Figure 33: US injectables pipeline and marketed drugs by molecule type
- Table Figure 34: US injectables pipeline and marketed drugs by therapy area
- Table Figure 35: US injectables pipeline by top 10 RoA
- Table Figure 36: US injectables pipeline by top 10 US review designations (Phase II-pre-registration)
- What it means
- Small number of contract packagers dominate innovative contracts
- Biologics drive marketed and pipeline drug packaging trends
- Pandemic shapes contract packaging demand
- Injectables have large/mega cap sponsors
- Future of injectables is self-administration
- Value Chain
- Table Figure 37: The contract manufacturing value chain
- Companies
- Table CPOs receiving packaging contracts for FDA approvals in 2012-21
- Table CPOs packaging site numbers and contract business model
- Appendix
- Methodology
- Bibliography
- Primary research - Key Opinion Leaders
- Further reading
- Table Further reading
- About the Authors
- Contact Us
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook